Stockreport

Biotech Stock Rockets To Record On Gene Therapy Trial In Children [Investor's Business Daily]

GSK plc American Depositary Shares (Each representing two Ordinary Shares)  (GSK) 
US:NYSE Investor Relations: gsk.com/en-gb/investors
PDF Technology Related news 1/03/2018 Spark and GlaxoSmithKline are pricing the world's first approved gene therapies at prices approaching $1 million. Biotech Gains First [Read more]